VP, R&D
Mon, Jan 3, 2022
Jan 3
20,000 shares @ $38.34
Increased holdings by +648.70%
Net across this filing: 0.00% (+0 shares)
8th largest trade (out of 94)
Option Exercise
Trade made by an officer
Sale tied to a same-time option exercise
Net holdings across this filing: +0.0% (+0 shares)
0% win rate · -7.3% median edge vs SPY (5 trades, 90-day · small sample)
Insider trade was 59% below market price
Price 14% above 200-day moving average
Win rate excludes trades classified as routine (tax, 10b5-1, exercise, gift).